Argentina Pharmaceutical Market Size, Share, Trends and Forecast by Type, Nature, and Region, 2025-2033

Argentina Pharmaceutical Market Size, Share, Trends and Forecast by Type, Nature, and Region, 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A42759

Argentina Pharmaceutical Market Overview:

The Argentina pharmaceutical market size reached USD 11.52 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 21.46 Billion by 2033, exhibiting a growth rate (CAGR) of 6.42% during 2025-2033. The market is driven by regulatory modernization and the rapid expansion of the biosimilar segment, enhancing accessibility and competitive dynamics. Advancements in mRNA technology transfer and the development of robust manufacturing infrastructure are strengthening production capabilities. Additionally, economic pressures are prompting market consolidation and fostering innovation, reshaping the pharmaceutical landscape. These combined factors are opening new avenues for growth, regional collaboration, and strategic investments, collectively contributing to the expansion of the Argentina pharmaceutical market share.

Report Attribute 
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024 USD 11.52 Billion
Market Forecast in 2033 USD 21.46 Billion
Market Growth Rate 2025-2033 6.42%


Argentina Pharmaceutical Market Trends:

Regulatory Modernization and Biosimilar Market Expansion

Argentina's pharmaceutical regulatory framework has undergone significant modernization, with ANMAT (National Administration of Drugs, Food and Medical Technology) implementing enhanced biosimilar regulations and streamlined approval processes. The measures introduced through Decree 1741/2025 represent an important step toward a more inclusive and sustainable healthcare system in the country, with 28 biosimilars authorized to date, highlighting the maturity of the regulatory system. This regulatory advancement positions Argentina as a regional leader in biosimilar development and manufacturing. The country has developed specific regulations including Reg. 7729/11 for biosimilar registration requirements and the recent Reg. 741/2025 defining comparability criteria. This regulatory evolution supports domestic production capabilities while ensuring international compliance standards, making Argentina an attractive destination for pharmaceutical investment and regional manufacturing hubs.

mRNA Technology Transfer and Manufacturing Infrastructure Development

Argentina has emerged as a key player in regional mRNA vaccine production through strategic partnerships with international organizations. In September 2021, PAHO announced that Sinergium Biotech, in Argentina, and the Institute of Technology in Immunobiologicals of the Oswaldo Cruz Foundation (Bio-Manguinhos/Fiocruz), in Brazil, were selected for technology transfer under an international cooperation initiative. This initiative represents a fundamental shift toward regional pharmaceutical self-sufficiency and pandemic preparedness. The mRNA technology transfer program involves collaboration between WHO, PAHO, and the Medicines Patent Pool to establish sustainable vaccine production capabilities. Argentina's participation in this program strengthens its biotechnology infrastructure and positions the country as a strategic supplier for the region, reducing dependence on imports during health emergencies and fostering technological innovation, boosting Argentina pharmaceutical market growth.

Economic Pressures Driving Market Consolidation and Innovation

The Argentine pharmaceutical market has experienced significant economic pressures, including currency devaluation and pricing challenges that are reshaping industry dynamics. Data from the Argentine Confederation of Medium-Sized Enterprises shows that pharmacy sales dropped 39% year-on-year at constant prices and are down 42% in the first two months of 2024, reflecting broader economic challenges facing the healthcare sector. Despite these challenges, the market is adapting through increased focus on local production, generic drug development, and biosimilar manufacturing. This economic environment is driving pharmaceutical companies to pursue more efficient operations, strategic partnerships, and innovative business models. The pressure is also accelerating adoption of cost-effective manufacturing technologies and promoting regional collaboration to reduce dependency on expensive imported pharmaceuticals while maintaining market competitiveness and ensuring continued access to essential medicines, highlighting key Argentina pharmaceutical market trends.

Argentina Pharmaceutical Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on type and nature.

Type Insights:

  • Pharmaceutical Drugs
    • Cardiovascular Drugs
    • Dermatology Drugs
    • Gastrointestinal Drugs
    • Genito-Urinary Drugs
    • Hematology Drugs
    • Anti-Infective Drugs
    • Metabolic Disorder Drugs
    • Musculoskeletal Disorder Drugs
    • Central Nervous System Drugs
    • Oncology Drugs
    • Ophthalmology Drugs
    • Respiratory Diseases Drugs
  • Biologics
    • Monoclonal Antibodies (MAbS)
    • Therapeutic Proteins
    • Vaccines

A detailed breakup and analysis of the market based on type have also been provided in the report. This includes pharmaceutical drugs (cardiovascular drugs, dermatology drugs, gastrointestinal drugs, genito-urinary drugs, hematology drugs, anti-infective drugs, metabolic disorder drugs, musculoskeletal disorder drugs, central nervous system drugs, oncology drugs, ophthalmology drugs, and respiratory diseases drugs) and biologics (monoclonal antibodies (MAbS), therapeutic proteins, and vaccines).

Nature Insights:

  • Organic
  • Conventional

The report has provided a detailed breakup and analysis of the market based on nature. This includes organic and conventional.

Regional Insights:

  • Buenos Aires Region
  • Litoral Region
  • Northern Region
  • Cordoba Region
  • Cuyo Region
  • Patagonia Region

The report has also provided a comprehensive analysis of all the major regional markets, which include Buenos Aires Region, Litoral Region, Northern Region, Cordoba Region, Cuyo Region, and Patagonia Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Argentina Pharmaceutical Market News:

  • January 2025: PAHO, the Government of Argentina, Pfizer, and Sinergium Biotech announced a joint collaboration to facilitate local production and regional access to the 20-valent pneumococcal conjugate vaccine (PCV20). This vaccine will help reduce the burden of pneumococcal diseases and will be available to Latin America and the Caribbean starting in early 2025, with the first Argentina-produced doses expected by 2026.
  • July 2024: Sinergium Biotech was selected to lead a new project aimed at accelerating the development and accessibility of human avian influenza (H5N1) messenger RNA vaccine candidates for manufacturers in low- and middle-income countries, leveraging the WHO and Medicines Patent Pool mRNA Technology Transfer Programme.

Argentina Pharmaceutical Market Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Scope of the Report

Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:

  • Type
  • Nature
  • Region
Modalities Covered
  • Pharmaceutical Drugs: Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs
  • Biologics: Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines
Natures Covered Organic, Conventional
Regions Covered Buenos Aires Region, Litoral Region, Northern Region, Cordoba Region, Cuyo Region, Patagonia Region
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the Argentina pharmaceutical market performed so far and how will it perform in the coming years?
  • What is the breakup of the Argentina pharmaceutical market on the basis of type?
  • What is the breakup of the Argentina pharmaceutical market on the basis of nature?
  • What is the breakup of the Argentina pharmaceutical market on the basis of region?
  • What are the various stages in the value chain of the Argentina pharmaceutical market?
  • What are the key driving factors and challenges in the Argentina pharmaceutical market?
  • What is the structure of the Argentina pharmaceutical market and who are the key players?
  • What is the degree of competition in the Argentina pharmaceutical market?

Key Benefits for Stakeholders:

  • IMARC's industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Argentina pharmaceutical market from 2019-2033.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the Argentina pharmaceutical market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Argentina pharmaceutical industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Argentina Pharmaceutical Market Size, Share, Trends and Forecast by Type, Nature, and Region, 2025-2033
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-201-971-6302

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials